1350545-83-3Relevant academic research and scientific papers
Design, synthesis, and biological evaluation of 4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridine derivatives as novel dual-PLK1/BRD4 inhibitors
Hu, Rong,Liu, Zhi-Hao,Shi, Yao-Jie,Wang, Ning-Yu,Wang, Wan-Li,Xiao, Kun-Jie,Xu, Ying,Yu, Luo-Ting,Zhu, Yong-Xia,Zuo, Wei-Qiong
, (2020)
Protein kinase inhibitors and epigenetic regulatory molecules are two main kinds of anticancer drugs developed in recent years. Both kinds of drugs harbor their own advantages and disadvantages in the treatment of cancer, and the development of small mole
